Acetic Acid


B. Braun Medical Inc.
Human Prescription Drug
NDC 0264-2304
Acetic Acid is a human prescription drug labeled by 'B. Braun Medical Inc.'. National Drug Code (NDC) number for Acetic Acid is 0264-2304. This drug is available in dosage form of Irrigant. The names of the active, medicinal ingredients in Acetic Acid drug includes Acetic Acid - .25 g/100mL . The currest status of Acetic Acid drug is Active.

Drug Information:

Drug NDC: 0264-2304
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Acetic Acid
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Acetic Acid
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: B. Braun Medical Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Irrigant
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ACETIC ACID - .25 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:IRRIGATION
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: NDA
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 06 Aug, 1979
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 02 Jan, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: NDA018161
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:B. Braun Medical Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:307707
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0302642304004
0302642304103
UPC stands for Universal Product Code.
UNII:Q40Q9N063P
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0264-2304-0016 CONTAINER in 1 CASE (0264-2304-00) / 1000 mL in 1 CONTAINER06 Aug, 1979N/ANo
0264-2304-1016 CONTAINER in 1 CASE (0264-2304-10) / 500 mL in 1 CONTAINER06 Aug, 1979N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Acetic acid acetic acid acetic acid acetic acid water

Indications and Usage:

Indications and usage 0.25% acetic acid irrigation usp is indicated as a constant or intermittent bladder rinse to help prevent the growth and proliferation of susceptible urinary pathogens (especially ammonia-forming bacteria) in the management of patients who require prolonged placement of an indwelling urethral catheter. it also may be used for periodic irrigation of an indwelling catheter to help maintain patency by reducing the formation of calcium encrustations.

Warnings:

Warnings for urologic irrigation only. not for injection. use of this solution in patients with mucosal lesions of the urinary bladder may be harmful due to irritation of the lesion. absorption via open lesions of the bladder mucosa may result in systemic acidosis. do not warm above 150°f (66°c). after opening container, the contents should be used promptly in order to minimize the possibility of bacterial growth or pyrogen formation. discard unused portion of irrigating solution since it contains no preservative.

General Precautions:

General use aseptic technique when preparing and administering sterile irrigation solutions. use only if solution is clear and container and seal are intact. if pain or hematuria should occur during irrigation, it should be discontinued and the patient reevaluated. when used for irrigation via appropriate irrigation equipment, the administration set should be attached promptly. unused portions should be discarded and a fresh container of appropriate size used for the start up of each cycle or repeat procedure. for repeated irrigations of urethral catheters, a separate container should be used for each patient.

Dosage and Administration:

Dosage and administration as required for urologic irrigation. 0.25% acetic acid irrigation usp may be administered by gravity drip via an administration set connected to an indwelling urethral catheter designed for continuous or intermittent two-way flow. for continuous or intermittent irrigation, the rate of administration will correspond roughly to the rate of urine flow and should be adjusted to maintain a urinary effluent ph of 4.5 to 5.0. nitrazine or other ph paper may be used to monitor ph, preferably at least four times daily. drip rate should be adjusted as necessary to maintain desired ph; increasing flow rate reduces ph value and vice versa. with continuous or intermittent irrigation, each patient will require a volume of approximately 500 to 1500 ml per 24 hours. some additives may be incompatible. consult with pharmacist. when introducing additives, use aseptic techniques. mix thoroughly. do not store. this drug product should be inspected visually for particulate matter
and discoloration prior to administration, whenever solution and container permit.

Contraindications:

Contraindications 0.25% acetic acid irrigation usp is not for injection. this solution is contraindicated for irrigation during transurethral surgical procedures.

Adverse Reactions:

Adverse reactions systemic acidosis, pain, and hematuria have been reported in patients receiving urinary bladder irrigation with 0.25% acetic acid solution. if an adverse reaction does occur, discontinue administration of the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination, if deemed necessary.

Use in Pregnancy:

Pregnancy teratogenic effects pregnancy category c animal reproduction studies have not been conducted with 0.25% acetic acid irrigation usp. it is also not known whether 0.25% acetic acid irrigation usp can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 0.25% acetic acid irrigation usp should be given to a pregnant woman only if clearly needed.

Pediatric Use:

Pediatric use safety and effectiveness in pediatric patients have not been established.

Geriatric Use:

Geriatric use clinical studies of 0.25% acetic acid irrigation usp have not been performed to determine whether patients over 65 years of age respond differently from younger subjects. although systemic absorption of the product is unlikely, greater sensitivity of some older individuals cannot be ruled out.

Overdosage:

Overdosage systemic absorption is unlikely unless there are open lesions of the bladder mucosa that have gone undetected. in such event, discontinue the irrigation, evaluate the patient for possible systemic acidosis, intravascular hemolysis, and circulatory overload and institute appropriate countermeasures as indicated. see warnings , precautions , and adverse reactions .

Description:

Description each 100 ml contains: glacial acetic acid usp 0.25 g water for injection usp qs ph: 3.1 (2.8–3.4) calculated osmolarity: 42 mosmol/liter the formula of the active ingredient is: ingredient molecular formula molecular weight glacial acetic acid usp ch 3 cooh 60.05 0.25% acetic acid irrigation usp is a prediluted, sterile, nonpyrogenic aqueous solution suitable for urologic irrigation. it contains no preservatives or added buffers. the solution is hypotonic. the plastic container is a copolymer of ethylene and propylene formulated and developed for parenteral drugs. the copolymer contains no plasticizers and exhibits virtually no leachability. the plastic container is also virtually impermeable to vapor transmission and therefore, requires no overwrap to maintain the proper drug concentration. the safety of the plastic container has been confirmed by biological evaluation procedures. the material passes class vl testing as specified in the u.s. pharmacopeia for biological tests — plastic containers. these tests have shown that the container is nontoxic and biologically inert. the pic™ container is pvc-free and dehp-free.

Clinical Pharmacology:

Clinical pharmacology irrigation of the urinary bladder with acetic acid solution in a concentration of 0.25% has been shown to exert an antimicrobial action against a variety of microorganisms (especially ammonia-forming bacteria) that frequently gain access to the urinary bladder in patients who require prolonged indwelling urethral catheterization. its antimicrobial action is dependent on administration via the indwelling catheter at a sufficient rate (continuous or intermittent) to maintain an effluent ph of 5.0 or lower. maintenance of low ph of bladder urine also helps reduce formation of calcium encrustations in the indwelling catheter.

Carcinogenesis and Mutagenesis and Impairment of Fertility:

Carcinogenesis, mutagenesis, impairment of fertility studies with 0.25% acetic acid irrigation usp have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.

How Supplied:

How supplied 0.25% acetic acid irrigation usp is supplied sterile and nonpyrogenic in 1000 ml and 500 ml pic™ (plastic irrigation containers) packaged 16 per case. ndc cat. no. size 0.25% acetic acid irrigation usp 0264-2304-00 r6600-01 1000 ml 0264-2304-10 r6601-01 500 ml exposure of pharmaceutical products to heat should be minimized. avoid excessive heat. protect from freezing. it is recommended that the product be stored at room temperature (25°c); however, brief exposure up to 40°c does not adversely affect the product. do not warm above 150°f (66°c).

Spl Patient Package Insert:

Directions for use of pic containers not for injection. aseptic technique is required. caution – before use, perform the following checks: (a) read the label. ensure solution is the one ordered and is within the expiration date. (b) invert container and inspect the solution in good light for cloudiness, haze, or particulate matter; check the container for leakage or damage. any container which is suspect should not be used. use only if solution is clear and container and seal are intact. single dose container. discard unused portion. outer closure removal – grasp the container with one hand and turn the breakaway ring counterclockwise with the other hand until slight resistance is felt. then, twisting the container in the opposite direction, turn the breakaway ring sharply until the entire outer cap is loose and can be lifted off. connect the administration set through the sterile set port according to set instructions or remove screw cap and pour. do not warm above 150°f
to assure minimal bottle distortion. keep bottles upright. figure 1 figure 2

Package Label Principal Display Panel:

Principal display panel - 1000 ml bag label 0.25% acetic acid irrigation usp ref r6600-01 ndc 0264-2304-00 1000 ml each 100 ml contains: glacial acetic acid usp 0.25 g water for injection usp qs ph: 3.1 (2.8–3.4) calc. osmolarity: 42 mosmol/liter, hypotonic not for injection or transurethral surgery: use only if solution is clear and container and seal are intact. sterile, nonpyrogenic. single dose container. warning: do not warm above 150°f (66°c). recommended storage: room temperature (25°c). avoid excessive heat. protect from freezing. see package insert. rx only pvc-free and dehp-free b. braun medical inc. irvine, ca 92614-5895 usa made in usa lot exp. y37-002-327 r6600-01 1000 ml container label

Principal display panel - 500 ml bag label 0.25% acetic acid irrigation usp ref r6601-01 ndc 0264-2304-10 500 ml each 100 ml contains: glacial acetic acid usp 0.25 g water for injection usp qs ph: 3.1 (2.8–3.4) calc. osmolarity: 42 mosmol/liter, hypotonic not for injection or transurethral surgery: use only if solution is clear and container and seal are intact. sterile, nonpyrogenic. single dose container. warning: do not warm above 150°f (66°c). recommended storage: room temperature (25°c). avoid excessive heat. protect from freezing. see package insert. rx only pvc-free and dehp-free b. braun medical inc. irvine, ca 92614-5895 usa made in usa lot exp. y37-002-328 r6601-01 500 ml container label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.